TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells

Biochemical and Biophysical Research Communications

Volumn 438, Issue 1, 2013, Pages 205-210

  Kokabu, Shoichiro ^a,b   Nguyen, Tan ^a   Ohte, Satoshi ^a   Sato, Tsuyoshi ^b   Katagiri, Takenobu ^c   Yoda, Tetsuya ^b   Rosen, Vicki ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adipogenesis; HDAC; Osteoblastogenesis; Osteoporosis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RUNX2; TRANSDUCIN; TRANSDUCING LIKE ENHANCER OF SPLIT 3; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL; SUPPRESSOR CELL;

EID: 84881551801     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.054     Document Type: Article

References (44)

1. Nuttall M.E., Gimble J.M. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr. Opin. Pharmacol. 2004, 4:290-294.
2. Harvey N., Dennison E., Cooper C. Osteoporosis: impact on health and economics. Nat. Rev. Rheumatol. 2010, 6:99-105.
3. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J. Bone Miner. Res. 2007, 22:465-475.
4. Raisz L.G., Elderkin A.L., Schargorodski L., Hart T., Waldman C., King T., Noonan A.S. A call to action: developing and implementing a national action plan to improve bone health. Osteoporos. Int. 2009, 20:1805-1806.
5. Tosteson A. Cost-effectiveness of Osteoporosis Treatment 2009, ASBMR, Washington.
6. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14:1293-1307.
7. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
8. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
9. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
10. Xu S.C., Harris M.A., Rubenstein J.L., Mundy G.R., Harris S.E. Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. DNA Cell Biol. 2001, 20:359-365.
11. Miyama K., Yamada G., Yamamoto T.S., Takagi C., Miyado K., Sakai M., Ueno N., Shibuya H. A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev. Biol. 1999, 208:123-133.
12. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
13. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
14. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779.
15. Lee B., Thirunavukkarasu K., Zhou L., Pastore L., Baldini A., Hecht J., Geoffroy V., Ducy P., Karsenty G. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 1997, 16:307-310.
16. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., Zaidi S.K., Young D.W., Choi J.Y., Pockwinse S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
17. Drissi H., Luc Q., Shakoori R., Chuva de Sousa Lopes S., Choi J.Y., Terry A., Hu M., Jones S., Neil J.C., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 2000, 184:341-350.
18. Nishimura R., Hata K., Ikeda F., Ichida F., Shimoyama A., Matsubara T., Wada M., Amano K., Yoneda T. Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J. Bone Miner. Metab. 2008, 26:203-212.
19. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M.Y., Takeyama K., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell Biol. 2007, 9:1273-1285.
20. Iwata T., Kawamoto T., Sasabe E., Miyazaki K., Fujimoto K., Noshiro M., Kurihara H., Kato Y. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells. Eur. J. Cell Biol. 2006, 85:423-431.
21. Tokuzawa Y., Yagi K., Yamashita Y., Nakachi Y., Nikaido I., Bono H., Ninomiya Y., Kanesaki-Yatsuka Y., Akita M., Motegi H., Wakana S., Noda T., Sablitzky F., Arai S., Kurokawa R., Fukuda T., Katagiri T., Schonbach C., Suda T., Mizuno Y., Okazaki Y. Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet. 2010, 6:e1001019.
22. Villanueva C.J., Waki H., Godio C., Nielsen R., Chou W.L., Vargas L., Wroblewski K., Schmedt C., Chao L.C., Boyadjian R., Mandrup S., Hevener A., Saez E., Tontonoz P. TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metab. 2011, 13:413-427.
23. Graves R.A., Tontonoz P., Spiegelman B.M. Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression. Mol. Cell. Biol. 1992, 12:1202-1208.
24. Kokabu S., Ohte S., Sasanuma H., Shin M., Yoneyama K., Murata E., Kanomata K., Nojima J., Ono Y., Yoda T., Fukuda T., Katagiri T. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a smad phosphatase. Mol. Endocrinol. 2011, 25:474-481.
25. Thies R.S., Bauduy M., Ashton B.A., Kurtzberg L., Wozney J.M., Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992, 130:1318-1324.
26. Ohte S., Kokabu S., Iemura S., Sasanuma H., Yoneyama K., Shin M., Suzuki S., Fukuda T., Nakamura Y., Jimi E., Natsume T., Katagiri T. Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling. J. Cell. Biochem. 2012, 113:808-814.
27. Nojima J., Kanomata K., Takada Y., Fukuda T., Kokabu S., Ohte S., Takada T., Tsukui T., Yamamoto T.S., Sasanuma H., Yoneyama K., Ueno N., Okazaki Y., Kamijo R., Yoda T., Katagiri T. Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J. Biol. Chem. 2010, 285:15577-15586.
28. Kanomata K., Kokabu S., Nojima J., Fukuda T., Katagiri T. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells 2009, 14:695-702.
29. Gupta R.K., Arany Z., Seale P., Mepani R.J., Ye L., Conroe H.M., Roby Y.A., Kulaga H., Reed R.R., Spiegelman B.M. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464:619-623.
30. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., Einhorn T., Tabin C.J., Rosen V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 2006, 38:1424-1429.
31. Lowery J.W., Frump A.L., Anderson L., DiCarlo G.E., Jones M.T., de Caestecker M.P. ID family protein expression and regulation in hypoxic pulmonary hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1463-R1477.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
33. Kokabu S., Gamer L., Cox K., Lowery J., Tsuji K., Raz R., Economides A., Katagiri T., Rosen V. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 2012, 26:87-94.
34. Westendorf J.J. Transcriptional co-repressors of Runx2. J. Cell. Biochem. 2006, 98:54-64.
35. McLarren K.W., Lo R., Grbavec D., Thirunavukkarasu K., Karsenty G., Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. J. Biol. Chem. 2000, 275:530-538.
36. Javed A., Guo B., Hiebert S., Choi J.Y., Green J., Zhao S.C., Osborne M.A., Stifani S., Stein J.L., Lian J.B., van Wijnen A.J., Stein G.S. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J. Cell Sci. 2000, 113(Pt 12):2221-2231.
37. Gasperowicz M., Otto F. Mammalian Groucho homologs: redundancy or specificity?. J. Cell. Biochem. 2005, 95:670-687.
38. Hata K., Nishimura R., Ueda M., Ikeda F., Matsubara T., Ichida F., Hisada K., Nokubi T., Yamaguchi A., Yoneda T. A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol. Cell. Biol. 2005, 25:1971-1979.
39. Peterson C.L., Laniel M.A. Histones and histone modifications. Curr. Biol. 2004, 14:R546-551.
40. Westendorf J.J., Zaidi S.K., Cascino J.E., Kahler R., van Wijnen A.J., Lian J.B., Yoshida M., Stein G.S., Li X. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 2002, 22:7982-7992.
41. Schroeder T.M., Kahler R.A., Li X., Westendorf J.J. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 2004, 279:41998-42007.
42. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J.M., Richardson J.A., Karsenty G., Olson E.N. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
43. Kang J.S., Alliston T., Delston R., Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 2005, 24:2543-2555.
44. Jensen E.D., Schroeder T.M., Bailey J., Gopalakrishnan R., Westendorf J.J. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J. Bone Miner. Res. 2008, 23:361-372.